| Year |
Citation |
Score |
| 2020 |
Richardson TE, Kumar A, Xing C, Hatanpaa KJ, Walker JM. Overcoming the Odds: Toward a Molecular Profile of Long-Term Survival in Glioblastoma. Journal of Neuropathology and Experimental Neurology. 79: 1031-1037. PMID 32954439 DOI: 10.1093/Jnen/Nlaa102 |
0.347 |
|
| 2020 |
Carter AM, Tan C, Pozo K, Telange R, Molinaro R, Guo A, De Rosa E, Martinez JO, Zhang S, Kumar N, Takahashi M, Wiederhold T, Ghayee HK, Oltmann SC, Pacak K, ... ... Hatanpaa KJ, et al. Phosphoprotein-based biomarkers as predictors for cancer therapy. Proceedings of the National Academy of Sciences of the United States of America. PMID 32690709 DOI: 10.1073/Pnas.2010103117 |
0.306 |
|
| 2020 |
Christian ZK, Hatanpaa KJ, Auchus RJ, Hammes SR, Patel AR, Mickey BE. Dopamine agonist and tamoxifen combination therapy for a prolactin-secreting pituitary tumor resistant to dopamine agonist monotherapy: Case report and review Interdisciplinary Neurosurgery. 21: 100777. DOI: 10.1016/J.Inat.2020.100777 |
0.321 |
|
| 2019 |
Neeley OJ, Al-Hreish KM, Aoun SG, El Ahmadieh TY, Plitt A, Vance AZ, Jaso JM, Hatanpaa KJ, White JA. Tumoral Mimics of Subdural Hematomas: Case report and Review of Diagnostic and Management Strategies in Primary B-Cell Lymphoma of the Subdural Space. World Neurosurgery. PMID 31562973 DOI: 10.1016/J.Wneu.2019.09.091 |
0.312 |
|
| 2019 |
Guo G, Gong K, Puliyapaddamba VT, Panchani N, Pan E, Mukherjee B, Damanwalla Z, Bharia S, Hatanpaa KJ, Gerber DE, Mickey BE, Patel TR, Sarkaria JN, Zhao D, Burma S, et al. Efficacy of EGFR plus TNF inhibition in a preclinical model of temozolomide-resistant glioblastoma. Neuro-Oncology. PMID 31363754 DOI: 10.1093/Neuonc/Noz127 |
0.331 |
|
| 2019 |
Mirchia K, Sathe AA, Walker JM, Fudym Y, Galbraith K, Viapiano MS, Corona RJ, Snuderl M, Xing C, Hatanpaa KJ, Richardson TE. Total copy number variation as a prognostic factor in adult astrocytoma subtypes. Acta Neuropathologica Communications. 7: 8. PMID 31177992 DOI: 10.1186/S40478-019-0746-Y |
0.341 |
|
| 2019 |
Todorova PK, Fletcher-Sananikone E, Mukherjee B, Kollipara R, Vemireddy V, Xie XJ, Guida PM, Story MD, Hatanpaa K, Habib AA, Kittler R, Bachoo R, Hromas R, Floyd JR, Burma S. Radiation-induced DNA damage cooperates with heterozygosity of TP53 and PTEN to generate high grade gliomas. Cancer Research. PMID 31088835 DOI: 10.1158/0008-5472.Can-19-0680 |
0.319 |
|
| 2019 |
Richardson TE, Patel S, Serrano J, Sathe AA, Daoud EV, Oliver D, Maher EA, Madrigales A, Mickey BE, Taxter T, Jour G, White CL, Raisanen JM, Xing C, Snuderl M, ... Hatanpaa KJ, et al. Genome-Wide Analysis of Glioblastoma Patients with Unexpectedly Long Survival. Journal of Neuropathology and Experimental Neurology. PMID 31034050 DOI: 10.1093/Jnen/Nlz025 |
0.361 |
|
| 2019 |
Prasanna P, Rogers L, Lam TC, Cohen M, Siddalingappa A, Wolansky L, Pinho M, Gupta A, Hatanpaa KJ, Madabhushi A, Tiwari P. Disorder in Pixel-Level Edge Directions on T1WI Is Associated with the Degree of Radiation Necrosis in Primary and Metastatic Brain Tumors: Preliminary Findings. Ajnr. American Journal of Neuroradiology. PMID 30733252 DOI: 10.3174/Ajnr.A5958 |
0.322 |
|
| 2019 |
Daoud EV, Wachsmann M, Richardson TE, Mella D, Pan E, Schwarzbach A, Oliver D, Hatanpaa KJ. Spinal Pleomorphic Xanthoastrocytoma With a QKI-RAF1 Fusion. Journal of Neuropathology and Experimental Neurology. 78: 10-14. PMID 30517658 DOI: 10.1093/Jnen/Nly112 |
0.351 |
|
| 2018 |
Richardson TE, Wachsmann M, Oliver D, Abedin Z, Ye D, Burns DK, Raisanen JM, Greenberg BM, Hatanpaa KJ. BRAF mutation leading to central nervous system Rosai-Dorfman disease. Annals of Neurology. PMID 30014527 DOI: 10.1002/Ana.25281 |
0.326 |
|
| 2018 |
Richardson TE, Sathe AA, Kanchwala M, Jia G, Habib AA, Xiao G, Snuderl M, Xing C, Hatanpaa KJ. Genetic and Epigenetic Features of Rapidly Progressing IDH-Mutant Astrocytomas. Journal of Neuropathology and Experimental Neurology. PMID 29741737 DOI: 10.1093/Jnen/Nly026 |
0.362 |
|
| 2018 |
Daoud EV, Rajaram V, Cai C, Oberle RJ, Martin GR, Raisanen JM, White CL, Foong C, Mickey BE, Pan E, Hatanpaa KJ. Adult Brainstem Gliomas With H3K27M Mutation: Radiology, Pathology, and Prognosis. Journal of Neuropathology and Experimental Neurology. PMID 29444279 DOI: 10.1093/Jnen/Nly006 |
0.372 |
|
| 2017 |
Richardson TE, Shen ZJ, Kanchwala M, Xing C, Filatenkov A, Shang P, Barnett S, Abedin Z, Malter JS, Raisanen JM, Burns DK, White CL, Hatanpaa KJ. Aggressive Behavior in Silent Subtype III Pituitary Adenomas May Depend on Suppression of Local Immune Response: A Whole Transcriptome Analysis. Journal of Neuropathology and Experimental Neurology. 76: 874-882. PMID 28922848 DOI: 10.1093/Jnen/Nlx072 |
0.313 |
|
| 2017 |
Guo G, Gong K, Ali S, Ali N, Shallwani S, Hatanpaa KJ, Pan E, Mickey B, Burma S, Wang DH, Kesari S, Sarkaria JN, Zhao D, Habib AA. A TNF-JNK-Axl-ERK signaling axis mediates primary resistance to EGFR inhibition in glioblastoma. Nature Neuroscience. PMID 28604685 DOI: 10.1038/Nn.4584 |
0.302 |
|
| 2017 |
Richardson TE, Snuderl M, Serrano J, Karajannis MA, Heguy A, Oliver D, Raisanen JM, Maher EA, Pan E, Barnett S, Cai C, Habib AA, Bachoo RM, Hatanpaa KJ. Rapid progression to glioblastoma in a subset of IDH-mutated astrocytomas: a genome-wide analysis. Journal of Neuro-Oncology. PMID 28421459 DOI: 10.1007/S11060-017-2431-Y |
0.361 |
|
| 2017 |
Botros J, Hatanpaa K, Isaacson B, Barnett SL. Calcified Middle Cranial Fossa Mass. Journal of Neurological Surgery Reports. 78. PMID 28255529 DOI: 10.1055/S-0037-1598112 |
0.33 |
|
| 2017 |
Richardson TE, Georgescu MM, Kapur P, Hwang H, Barnett SL, Raisanen JM, Cai C, Hatanpaa KJ. Unusual skull tumors with psammomatoid bodies: a diagnostic challenge. Clinical Neuropathology. PMID 28128725 DOI: 10.5414/Np300997 |
0.303 |
|
| 2017 |
Singh DK, Kollipara RK, Vemireddy V, Yang XL, Sun Y, Regmi N, Klingler S, Hatanpaa KJ, Raisanen J, Cho SK, Sirasanagandla S, Nannepaga S, Piccirillo S, Mashimo T, Wang S, et al. Oncogenes Activate an Autonomous Transcriptional Regulatory Circuit That Drives Glioblastoma. Cell Reports. 18: 961-976. PMID 28122245 DOI: 10.1016/J.Celrep.2016.12.064 |
0.337 |
|
| 2016 |
Choi C, Raisanen JM, Ganji SK, Zhang S, McNeil SS, An Z, Madan A, Hatanpaa KJ, Vemireddy V, Sheppard CA, Oliver D, Hulsey KM, Tiwari V, Mashimo T, Battiste J, et al. Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 4030-4039. PMID 28248126 DOI: 10.1200/Jco.2016.67.1222 |
0.337 |
|
| 2016 |
Hoes K, Hatanpaa KJ, Raisanen JM, Gluf WM. Epidural spinal cavernous hemangioma and hybrid vascular subtype. Clinical Neuropathology. 35: 368-374. PMID 27487399 DOI: 10.5414/Np300955 |
0.311 |
|
| 2016 |
Georgescu MM, Mobley BC, Orr BA, Shang P, Lehman NL, Zhu X, O'Neill TJ, Rajaram V, Hatanpaa KJ, Timmons CF, Raisanen JM. NHERF1/EBP50 and NF2 as diagnostic markers for choroid plexus tumors. Acta Neuropathologica Communications. 4: 55. PMID 27229317 DOI: 10.1186/S40478-016-0329-0 |
0.338 |
|
| 2015 |
Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, Cairns NJ, Crary JF, Duyckaerts C, Ghetti B, Halliday GM, Ironside JW, Love S, Mackenzie IR, Munoz DG, ... ... Hatanpaa KJ, et al. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathologica. PMID 26659578 DOI: 10.1007/S00401-015-1509-X |
0.304 |
|
| 2015 |
Richardson TE, Mathis DA, Mickey BE, Raisanen JM, Burns DK, White CL, Hatanpaa KJ. Clinical Outcome of Silent Subtype III Pituitary Adenomas Diagnosed by Immunohistochemistry. Journal of Neuropathology and Experimental Neurology. 74: 1170-1177. PMID 26574671 DOI: 10.1097/Nen.0000000000000265 |
0.305 |
|
| 2015 |
Alcantara Llaguno SR, Wang Z, Sun D, Chen J, Xu J, Kim E, Hatanpaa KJ, Raisanen JM, Burns DK, Johnson JE, Parada LF. Adult Lineage-Restricted CNS Progenitors Specify Distinct Glioblastoma Subtypes. Cancer Cell. 28: 429-40. PMID 26461091 DOI: 10.1016/J.Ccell.2015.09.007 |
0.361 |
|
| 2015 |
Georgescu MM, Yell P, Mobley BC, Shang P, Georgescu T, Wang SH, Canoll P, Hatanpaa KJ, White CL, Raisanen JM. NHERF1/EBP50 is an organizer of polarity structures and a diagnostic marker in ependymoma. Acta Neuropathologica Communications. 3: 11. PMID 25775275 DOI: 10.1186/S40478-015-0197-Z |
0.353 |
|
| 2014 |
Puliyappadamba VT, Hatanpaa KJ, Chakraborty S, Habib AA. The role of NF-κB in the pathogenesis of glioma Molecular and Cellular Oncology. 1. PMID 27308348 DOI: 10.4161/23723548.2014.963478 |
0.311 |
|
| 2014 |
Mashimo T, Pichumani K, Vemireddy V, Hatanpaa KJ, Singh DK, Sirasanagandla S, Nannepaga S, Piccirillo SG, Kovacs Z, Foong C, Huang Z, Barnett S, Mickey BE, DeBerardinis RJ, Tu BP, et al. Acetate is a bioenergetic substrate for human glioblastoma and brain metastases. Cell. 159: 1603-14. PMID 25525878 DOI: 10.1016/J.Cell.2014.11.025 |
0.31 |
|
| 2014 |
van Blitterswijk M, Mullen B, Wojtas A, Heckman MG, Diehl NN, Baker MC, DeJesus-Hernandez M, Brown PH, Murray ME, Hsiung GY, Stewart H, Karydas AM, Finger E, Kertesz A, Bigio EH, ... ... Hatanpaa KJ, et al. Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene. Molecular Neurodegeneration. 9: 38. PMID 25239657 DOI: 10.1186/1750-1326-9-38 |
0.302 |
|
| 2014 |
Triplett TM, Griffith A, Hatanpaa KJ, Barnett SL. Dermoid cyst of the infratemporal fossa: case report and review of the literature. Journal of Neurological Surgery Reports. 75: e33-7. PMID 25083385 DOI: 10.1055/S-0033-1358795 |
0.344 |
|
| 2014 |
van Blitterswijk M, Mullen B, Heckman MG, Baker MC, DeJesus-Hernandez M, Brown PH, Murray ME, Hsiung GY, Stewart H, Karydas AM, Finger E, Kertesz A, Bigio EH, Weintraub S, Mesulam M, ... Hatanpaa KJ, et al. Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers. Neurobiology of Aging. 35: 2421.e13-7. PMID 24866401 DOI: 10.1016/J.Neurobiolaging.2014.04.016 |
0.308 |
|
| 2014 |
Bit-Ivan EN, Lee KH, Gitelman D, Weintraub S, Mesulam M, Rademakers R, Isaacs AM, Hatanpaa KJ, White CL, Mao Q, Akman O, DiMauro S, Bigio EH. Adult polyglucosan body disease with GBE1 haploinsufficiency and concomitant frontotemporal lobar degeneration. Neuropathology and Applied Neurobiology. 40: 778-82. PMID 24750115 DOI: 10.1111/Nan.12144 |
0.307 |
|
| 2014 |
Sagiyama K, Mashimo T, Togao O, Vemireddy V, Hatanpaa KJ, Maher EA, Mickey BE, Pan E, Sherry AD, Bachoo RM, Takahashi M. In vivo chemical exchange saturation transfer imaging allows early detection of a therapeutic response in glioblastoma. Proceedings of the National Academy of Sciences of the United States of America. 111: 4542-7. PMID 24616497 DOI: 10.1073/Pnas.1323855111 |
0.325 |
|
| 2014 |
Hatanpaa KJ, Hu T, Vemireddy V, Foong C, Raisanen JM, Oliver D, Hiemenz MC, Burns DK, White CL, Whitworth LA, Mickey B, Stegner M, Habib AA, Fink K, Maher EA, et al. High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II-III astrocytomas and oligoastrocytomas. Journal of Neuro-Oncology. 117: 183-9. PMID 24519516 DOI: 10.1007/S11060-014-1376-7 |
0.309 |
|
| 2014 |
Shu F, Oberle R, Herndon E, Hatanpaa K, Battiste J, Vernino S. A rare adult cause of dizziness. Jama Neurology. 71: 360-3. PMID 24395371 DOI: 10.1001/Jamaneurol.2013.5839 |
0.308 |
|
| 2014 |
van Blitterswijk M, Mullen B, Nicholson AM, Bieniek KF, Heckman MG, Baker MC, DeJesus-Hernandez M, Finch NA, Brown PH, Murray ME, Hsiung GY, Stewart H, Karydas AM, Finger E, Kertesz A, ... ... Hatanpaa KJ, et al. TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia. Acta Neuropathologica. 127: 397-406. PMID 24385136 DOI: 10.1007/S00401-013-1240-4 |
0.308 |
|
| 2013 |
van Blitterswijk M, Baker MC, DeJesus-Hernandez M, Ghidoni R, Benussi L, Finger E, Hsiung GY, Kelley BJ, Murray ME, Rutherford NJ, Brown PE, Ravenscroft T, Mullen B, Ash PE, Bieniek KF, ... Hatanpaa KJ, et al. C9ORF72 repeat expansions in cases with previously identified pathogenic mutations. Neurology. 81: 1332-41. PMID 24027057 DOI: 10.1212/Wnl.0B013E3182A8250C |
0.309 |
|
| 2013 |
Ahmed Z, Bigio EH, Budka H, Dickson DW, Ferrer I, Ghetti B, Giaccone G, Hatanpaa KJ, Holton JL, Josephs KA, Powers J, Spina S, Takahashi H, White CL, Revesz T, et al. Globular glial tauopathies (GGT): consensus recommendations. Acta Neuropathologica. 126: 537-44. PMID 23995422 DOI: 10.1007/S00401-013-1171-0 |
0.326 |
|
| 2013 |
Rayaprolu S, Mullen B, Baker M, Lynch T, Finger E, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C, Josephs KA, Knopman DS, White CL, Caselli R, et al. TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease. Molecular Neurodegeneration. 8: 19. PMID 23800361 DOI: 10.1186/1750-1326-8-19 |
0.302 |
|
| 2013 |
Malafronte P, Clark HB, Castaneda-Sanchez I, Raisanen J, Hatanpaa KJ. Brown-Vialetto-Van Laere syndrome: clinical and neuropathologic findings with immunohistochemistry for C20orf54 in three affected patients. Pediatric and Developmental Pathology : the Official Journal of the Society For Pediatric Pathology and the Paediatric Pathology Society. 16: 364-71. PMID 23688382 DOI: 10.2350/13-02-1299-Cr.1 |
0.308 |
|
| 2013 |
Li W, Winters A, Poteet E, Ryou MG, Lin S, Hao S, Wu Z, Yuan F, Hatanpaa KJ, Simpkins JW, Yang SH. Involvement of estrogen receptor β5 in the progression of glioma. Brain Research. 1503: 97-107. PMID 23399685 DOI: 10.1016/J.Brainres.2013.02.004 |
0.304 |
|
| 2012 |
Marin-Valencia I, Yang C, Mashimo T, Cho S, Baek H, Yang XL, Rajagopalan KN, Maddie M, Vemireddy V, Zhao Z, Cai L, Good L, Tu BP, Hatanpaa KJ, Mickey BE, et al. Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo. Cell Metabolism. 15: 827-37. PMID 22682223 DOI: 10.1016/J.Cmet.2012.05.001 |
0.328 |
|
| 2012 |
Marin-Valencia I, Cho SK, Rakheja D, Hatanpaa KJ, Kapur P, Mashimo T, Jindal A, Vemireddy V, Good LB, Raisanen J, Sun X, Mickey B, Choi C, Takahashi M, Togao O, et al. Glucose metabolism via the pentose phosphate pathway, glycolysis and Krebs cycle in an orthotopic mouse model of human brain tumors. Nmr in Biomedicine. 25: 1177-86. PMID 22383401 DOI: 10.1002/Nbm.2787 |
0.315 |
|
| 2012 |
Choi C, Ganji SK, DeBerardinis RJ, Hatanpaa KJ, Rakheja D, Kovacs Z, Yang XL, Mashimo T, Raisanen JM, Marin-Valencia I, Pascual JM, Madden CJ, Mickey BE, Malloy CR, Bachoo RM, et al. 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas. Nature Medicine. 18: 624-9. PMID 22281806 DOI: 10.1038/Nm.2682 |
0.326 |
|
| 2011 |
Ross OA, Rutherford NJ, Baker M, Soto-Ortolaza AI, Carrasquillo MM, DeJesus-Hernandez M, Adamson J, Li M, Volkening K, Finger E, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, et al. Ataxin-2 repeat-length variation and neurodegeneration. Human Molecular Genetics. 20: 3207-12. PMID 21610160 DOI: 10.1093/Hmg/Ddr227 |
0.302 |
|
| 2011 |
Barnett SL, Wells MJ, Mickey B, Hatanpaa KJ. Perineural extension of cutaneous desmoplastic melanoma mimicking an intracranial malignant peripheral nerve sheath tumor. Case report. Journal of Neurosurgery. 115: 273-7. PMID 21548747 DOI: 10.3171/2011.4.Jns10913 |
0.324 |
|
| 2011 |
Yang X, Mashimo T, Su Y, Vemireddy V, Guntipalli P, Ramachandran A, Chaudhary P, Mickey B, Hatanpaa K, Maher E, Bachoo RM. Abstract 1111: Preclinical evaluation of CP868,596, a novel PDGFRα Inhibitor for treatment of glioblastoma Cancer Research. 71: 1111-1111. DOI: 10.1158/1538-7445.Am2011-1111 |
0.354 |
|
| 2010 |
Hatanpaa KJ, Burma S, Zhao D, Habib AA. Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance. Neoplasia (New York, N.Y.). 12: 675-84. PMID 20824044 DOI: 10.1593/Neo.10688 |
0.3 |
|
| 2010 |
Urwin H, Josephs KA, Rohrer JD, Mackenzie IR, Neumann M, Authier A, Seelaar H, Van Swieten JC, Brown JM, Johannsen P, Nielsen JE, Holm IE, Dickson DW, Rademakers R, ... ... Hatanpaa KJ, et al. FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathologica. 120: 33-41. PMID 20490813 DOI: 10.1007/S00401-010-0698-6 |
0.334 |
|
| 2010 |
Bigio EH, Mishra M, Hatanpaa KJ, White CL, Johnson N, Rademaker A, Weitner BB, Deng HX, Dubner SD, Weintraub S, Mesulam M. TDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease. Acta Neuropathologica. 120: 43-54. PMID 20361198 DOI: 10.1007/S00401-010-0681-2 |
0.333 |
|
| 2010 |
Marian CO, Cho SK, McEllin BM, Maher EA, Hatanpaa KJ, Madden CJ, Mickey BE, Wright WE, Shay JW, Bachoo RM. The telomerase antagonist, imetelstat, efficiently targets glioblastoma tumor-initiating cells leading to decreased proliferation and tumor growth. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 154-63. PMID 20048334 DOI: 10.1158/1078-0432.Ccr-09-2850 |
0.346 |
|
| 2010 |
Spears MD, Melton SD, Mao Q, Payne D, Rakheja D, Hatanpaa KJ, Burns DK, Sequeiros J, Alonso I. Ataxia and progressive encephalopathy in a 4-year-old girl Labmedicine. 41: 5-9. DOI: 10.1309/Lmsgol1I3U5Qtwrs |
0.301 |
|
| 2009 |
Kutz JW, Barnett SL, Hatanpaa KJ, Mendelsohn DB. Concurrent vestibular schwannoma and meningioma mimicking a single cerebellopontine angle tumor. Skull Base : Official Journal of North American Skull Base Society ... [Et Al.]. 19: 443-6. PMID 20436847 DOI: 10.1055/S-0029-1220206 |
0.326 |
|
| 2009 |
Mukherjee B, McEllin B, Camacho CV, Tomimatsu N, Sirasanagandala S, Nannepaga S, Hatanpaa KJ, Mickey B, Madden C, Maher E, Boothman DA, Furnari F, Cavenee WK, Bachoo RM, Burma S. EGFRvIII and DNA double-strand break repair: a molecular mechanism for radioresistance in glioblastoma. Cancer Research. 69: 4252-9. PMID 19435898 DOI: 10.1158/0008-5472.Can-08-4853 |
0.329 |
|
| 2009 |
Park S, Hatanpaa KJ, Xie Y, Mickey BE, Madden CJ, Raisanen JM, Ramnarain DB, Xiao G, Saha D, Boothman DA, Zhao D, Bachoo RM, Pieper RO, Habib AA. The receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma. Cancer Research. 69: 2809-16. PMID 19339267 DOI: 10.1158/0008-5472.Can-08-4079 |
0.322 |
|
| 2008 |
Hatanpaa KJ, Bigio EH, Cairns NJ, Womack KB, Weintraub S, Morris JC, Foong C, Xiao G, Hladik C, Mantanona TY, White CL. TAR DNA-binding protein 43 immunohistochemistry reveals extensive neuritic pathology in FTLD-U: a midwest-southwest consortium for FTLD study. Journal of Neuropathology and Experimental Neurology. 67: 271-9. PMID 18379440 DOI: 10.1097/Nen.0B013E31816A12A6 |
0.331 |
|
| 2008 |
Mukherjee O, Wang J, Gitcho M, Chakraverty S, Taylor-Reinwald L, Shears S, Kauwe JS, Norton J, Levitch D, Bigio EH, Hatanpaa KJ, White CL, Morris JC, Cairns NJ, Goate A. Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia. Human Mutation. 29: 512-21. PMID 18183624 DOI: 10.1002/Humu.20681 |
0.332 |
|
| 2007 |
Cairns NJ, Bigio EH, Mackenzie IR, Neumann M, Lee VM, Hatanpaa KJ, White CL, Schneider JA, Grinberg LT, Halliday G, Duyckaerts C, Lowe JS, Holm IE, Tolnay M, Okamoto K, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathologica. 114: 5-22. PMID 17579875 DOI: 10.1007/S00401-007-0237-2 |
0.349 |
|
| 2005 |
Raisanen J, Biegel JA, Hatanpaa KJ, Judkins A, White CL, Perry A. Chromosome 22q deletions in atypical teratoid/rhabdoid tumors in adults. Brain Pathology (Zurich, Switzerland). 15: 23-8. PMID 15779233 DOI: 10.1111/J.1750-3639.2005.Tb00096.X |
0.359 |
|
| 2004 |
Hatanpaa KJ, Blass DM, Pletnikova O, Crain BJ, Bigio EH, Hedreen JC, White CL, Troncoso JC. Most cases of dementia with hippocampal sclerosis may represent frontotemporal dementia. Neurology. 63: 538-42. PMID 15304590 DOI: 10.1212/01.Wnl.0000129543.46734.C0 |
0.325 |
|
| 2004 |
Wang M, Murphy KM, Kulesza P, Hatanpaa KJ, Olivi A, Tufaro A, Erozan Y, Westra WH, Burger PC, Berg KD. Molecular diagnosis of metastasizing oligodendroglioma: a case report. The Journal of Molecular Diagnostics : Jmd. 6: 52-7. PMID 14736827 DOI: 10.1016/S1525-1578(10)60491-6 |
0.346 |
|
| 1996 |
Chandrasekaran K, Hatanpää K, Brady DR, Rapoport SI. Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease. Experimental Neurology. 142: 80-8. PMID 8912900 DOI: 10.1006/Exnr.1996.0180 |
0.31 |
|
| Show low-probability matches. |
